Terns Pharmaceuticals, Inc.
TERNDelisted May 5, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001831363
Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.
13F holders, Q1 2023
Institutional positions in Terns Pharmaceuticals, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 79
- +14 vs. Q4 2022
- Shares held
- 53.2M
- +3.49M (+7.0%) vs. Q4 2022
- Total value
- $630.2M
- +$124.0M (+24.5%) vs. Q4 2022
- New holders
- 27
- 26 more added
- Sold out
- 13
- 15 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TERN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $75.4K |
| Q1 2026 | 317 | $6.56B |
| Q4 2025 | 248 | $4.95B |
| Q3 2025 | 141 | $665.7M |
| Q2 2025 | 130 | $310.0M |
| Q1 2025 | 138 | $229.4M |
| Q4 2024 | 157 | $477.2M |
| Q3 2024 | 156 | $663.1M |
| Q2 2024 | 126 | $446.7M |
| Q1 2024 | 112 | $414.8M |
| Q4 2023 | 103 | $412.7M |
| Q3 2023 | 93 | $310.4M |
| Q2 2023 | 103 | $505.0M |
| Q1 2023 | 79 | $630.2M |
| Q4 2022 | 65 | $506.2M |
| Q3 2022 | 45 | $178.1M |
| Q2 2022 | 42 | $36.5M |
| Q1 2022 | 44 | $50.0M |
| Q4 2021 | 37 | $116.7M |
| Q3 2021 | 34 | $174.3M |
| Q2 2021 | 36 | $203.8M |
| Q1 2021 | 42 | $393.7M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Terns Pharmaceuticals, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 7,642,758 | $90.5M | 0.01% | +264,117+3.6% | Added |
| OrbiMed Advisors LLC | 7,619,135 | $90.2M | 1.79% | 00.0% | Unchanged |
| Vivo Capital, LLC | 6,657,992 | $78.8M | 5.90% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,619,522 | $42.9M | 8.37% | −88,369−2.4% | Reduced |
| Suvretta Capital Management, LLC | 3,448,275 | $40.8M | 1.97% | 00.0% | Unchanged |
| Driehaus Capital Management LLC | 2,469,512 | $29.2M | 0.41% | +175,136+7.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,059,421 | $24.4M | 0.54% | −791,866−27.8% | Reduced |
| Fairmount Funds Management LLC | 2,040,000 | $24.2M | 4.15% | 00.0% | Unchanged |
| Braidwell LP | 1,997,055 | $23.6M | 0.78% | +1,997,055 | New |
| Franklin Resources Inc | 1,457,454 | $17.3M | 0.01% | +707,430+94.3% | Added |
| Perceptive Advisors LLC | 1,350,000 | $16.0M | 0.47% | +1,350,000 | New |
| Vanguard Group Inc | 1,291,249 | $15.3M | 0.00% | +165,213+14.7% | Added |
| Acuta Capital Partners, LLC | 1,099,309 | $13.0M | 10.13% | −691−0.1% | Reduced |
| Millennium Management LLC | 1,082,383 | $12.8M | 0.01% | −374,822−25.7% | Reduced |
| Ikarian Capital, LLC | 721,341 | $8.54M | 3.55% | −15,978−2.2% | Reduced |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $8.46M | 3.41% | 00.0% | Unchanged |
| BlackRock Inc. | 700,667 | $8.30M | 0.00% | +401,229+134.0% | Added |
| Silverarc Capital Management, LLC | 667,922 | $7.91M | 3.55% | −32,078−4.6% | Reduced |
| JPMorgan Chase & Co | 631,746 | $7.48M | 0.00% | −575,405−47.7% | Reduced |
| Point72 Asset Management, L.P. | 629,098 | $7.45M | 0.03% | +395,598+169.4% | Added |
| Invesco Ltd. | 574,177 | $6.80M | 0.00% | +574,177 | New |
| Barclays PLC | 534,760 | $6.33M | 0.01% | +18,021+3.5% | Added |
| Citadel Advisors LLC | 392,065 | $4.64M | 0.01% | −123,732−24.0% | Reduced |
| Balyasny Asset Management LLC | 367,671 | $4.35M | 0.01% | +367,671 | New |
| Susquehanna International Group, LLP | 328,028 | $3.88M | 0.01% | +289,926+760.9% | Added |
| Geode Capital Management, LLC | 304,716 | $3.61M | 0.00% | +127,068+71.5% | Added |
| Dimensional Fund Advisors LP | 237,111 | $2.81M | 0.00% | +138,171+139.7% | Added |
| Samsara BioCapital, LLC | 202,348 | $2.40M | 0.50% | 00.0% | Unchanged |
| Marshall Wace, LLP | 185,028 | $2.19M | 0.01% | +148,947+412.8% | Added |
| Jane Street Group, LLC | 149,361 | $1.77M | 0.00% | +127,854+594.5% | Added |
| HighVista Strategies LLC | 146,854 | $1.74M | 1.42% | +69,510+89.9% | Added |
| Morgan Stanley | 141,936 | $1.68M | 0.00% | +123,878+686.0% | Added |
| EAM Investors, LLC | 128,186 | $1.52M | 0.30% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 127,552 | $1.51M | 0.04% | +1,670+1.3% | Added |
| Velan Capital Investment Management LP | 120,000 | $1.42M | 1.26% | +109,354+1,027.2% | Added |
| State Street Corp | 119,039 | $1.41M | 0.00% | +59,502+99.9% | Added |
| Schonfeld Strategic Advisors LLC | 115,252 | $1.36M | 0.01% | +115,252 | New |
| Renaissance Technologies LLC | 105,200 | $1.25M | 0.00% | −9,700−8.4% | Reduced |
| Polar Asset Management Partners Inc. | 100,000 | $1.18M | 0.02% | 00.0% | Unchanged |
| Integral Health Asset Management, LLC | 100,000 | $1.18M | 0.25% | +100,000 | New |
| Goldman Sachs Group Inc | 89,304 | $1.06M | 0.00% | +78,474+724.6% | Added |
| Parkman Healthcare Partners LLC | 75,000 | $888.0K | 0.19% | +75,000 | New |
| Northern Trust Corp | 55,079 | $652.1K | 0.00% | +23,486+74.3% | Added |
| Atom Investors LP | 51,951 | $615.1K | 0.33% | +51,951 | New |
| Qube Research & Technologies Ltd | 50,951 | $603.3K | 0.00% | +40,406+383.2% | Added |
| Bridgeway Capital Management, LLC | 50,700 | $600.3K | 0.02% | −42,000−45.3% | Reduced |
| Royal Bank of Canada | 50,004 | $592.0K | 0.00% | +49,822+27,374.7% | Added |
| Bank of America Corp | 47,951 | $567.7K | 0.00% | +46,136+2,541.9% | Added |
| D. E. Shaw & Co., Inc. | 46,762 | $553.7K | 0.00% | +46,762 | New |
| Citigroup Inc | 45,393 | $537.5K | 0.00% | −655−1.4% | Reduced |
| Mirabella Financial Services LLP | 33,334 | $394.7K | 0.08% | +33,334 | New |
| Alps Advisors Inc | 31,603 | $374.2K | 0.00% | +6,078+23.8% | Added |
| Verition Fund Management LLC | 25,590 | $303.0K | 0.00% | +25,590 | New |
| Bank of New York Mellon Corp | 20,388 | $241.4K | 0.00% | +20,388 | New |
| Cubist Systematic Strategies, LLC | 20,356 | $241.0K | 0.00% | +15,491+318.4% | Added |
| Jump Financial, LLC | 18,356 | $217.3K | 0.01% | +18,356 | New |
| Fred Alger Management, LLC | 16,276 | $192.7K | 0.00% | +16,276 | New |
| 683 Capital Management, LLC | 16,000 | $189.4K | 0.02% | −12,000−42.9% | Reduced |
| LMR Partners LLP | 15,849 | $187.7K | 0.00% | +15,849 | New |
| Man Group plc | – | $164.2K | 0.00% | – | – |
| Charles Schwab Investment Management Inc | 13,711 | $162.3K | 0.00% | +13,711 | New |
| Squarepoint Ops LLC | 12,925 | $153.0K | 0.00% | +12,925 | New |
| Crosspoint Financial, LLC | 12,054 | $142.7K | 1.54% | −3,000−19.9% | Reduced |
| Connor, Clark & Lunn Investment Management Ltd. | 11,963 | $141.6K | 0.00% | +11,963 | New |
| UBS Group AG | 5,672 | $67.2K | 0.00% | +5,672 | New |
| Point72 Middle East FZE | 5,084 | $60.2K | 0.00% | +5,084 | New |
| Dark Forest Capital Management LP | 3,852 | $45.6K | 0.01% | +3,852 | New |
| Tower Research Capital LLC (TRC) | 3,650 | $43.0K | 0.00% | −1,889−34.1% | Reduced |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 2,482 | $29.4K | 0.00% | −2,568−50.9% | Reduced |
| China Universal Asset Management Co., Ltd. | 671 | $7.95K | 0.00% | +288+75.2% | Added |
| Wells Fargo & Company | 209 | $2.48K | 0.00% | +83+65.9% | Added |
| TCI Wealth Advisors, Inc. | 200 | $2.37K | 0.00% | +200 | New |
| Daiwa Securities Group Inc. | 151 | $2.00K | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 188 | $2.00K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 161 | $1.91K | 0.00% | +161 | New |
| Lindbrook Capital, LLC | 130 | $1.54K | 0.00% | +130 | New |
| Signaturefd, LLC | 103 | $1.22K | 0.00% | +103 | New |
| Belpointe Asset Management LLC | 100 | $1.18K | 0.00% | +100 | New |
| Aquatic Capital Management LLC | 100 | $1.00K | 0.00% | +100 | New |
| RTW Investments, LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −605,079−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −560,000−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −194,100−100.0% | Sold out |
| Endurant Capital Management LP | 0 | $0 | 0.00% | −135,994−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −122,500−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −73,611−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −35,090−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −22,599−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −15,709−100.0% | Sold out |
| Raymond James & Associates | 0 | $0 | 0.00% | −12,488−100.0% | Sold out |